- What are the recommended antibiotics for Aerococcus urinae infections?
Aerococcus urinae is a gram-positive coccus that typically causes urinary tract infections but can lead to more serious conditions like bacteremia, endocarditis, or sepsis, particularly in elderly patients with underlying urological conditions
- 1468. Determination of Antibiotic Susceptibilities in Aerococcus urinae . . .
The primary objective of this study was to establish the susceptibility rate of A urinae urinary isolates to cefazolin, ampicillin, nitrofurantoin, fosfomycin, and ciprofloxacin
- What antibiotics are effective against Aerococcus urinae infections?
Nitrofurantoin is the first-line treatment for Aerococcus urinae urinary tract infections, achieving clinical and microbiological success in 71-76% of cases
- Susceptibility of Aerococcus urinae and Aerococcus sanguinicola to . . .
In 2017, EUCAST introduced clinical breakpoints for A sanguinicola and A urinae, which now encompass benzylpenicillin, ampicillin, meropenem, ciprofloxacin, levofloxacin, vancomycin, rifampicin, and nitrofurantoin
- Infectious Diseases in Clinical Practice - LWW
A total of 64 unique A urinae isolates were recovered from the stored isolates All isolates were susceptible to ampicillin, penicillin, linezolid, nitrofurantoin, and vancomycin, while 92 1% were susceptible to tetracycline, 63 6% to levofloxacin, and 44 5% to ciprofloxacin
- Management and treatment of Aerococcus bacteremia and endocarditis . . .
Aerococcus urinae endocarditis may be treated with four weeks of intravenous penicillin or ceftriaxone monotherapy with good outcomes
- Levofloxacin - StatPearls - NCBI Bookshelf
Of the fluoroquinolone class, levofloxacin has the most enhanced activity against gram-positive penicillin-sensitive and resistant organisms, notably Streptococcus pneumoniae and reduced action against gram-negative bacilli, notably Pseudomonas aeruginosa, compared to ciprofloxacin
- Aerococcus Susceptibility to Antimicrobics
Clinical Laboratory Standards Institute (CLSI) M-45 3rd ed (2016) document outlines interpretations for penicillin, cefotaxime, ceftriaxone, meropenem, vancomycin, ciprofloxacin, levofloxacin, trimethoprim-sulfamethoxazole (excluding A urinae), and tetracycline
|